Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Seekyo Adds Diagnostics and Theranostics Capabilities to Its Lead Compound SKY01 That Targets Solid Tumors
Seekyo, a startup specializing in developing smart chemotherapy drugs, today announces the availability of personalized […]
MindMed Announces Transition of CFO
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED) (the “Company” or “MindMed”), a clinical stage biopharmaceutical company […]
New State-Of-The-Art NHS Hospital To Help Tackle Covid Backlog
A new ‘planned care’ hospital dedicated to non-emergency treatment is due to open in Berkshire […]
Innovent and Lilly Expand Strategic Partnership in Oncology
Innovent Biologics, Inc. (“Innovent”, HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes […]
CND Life Sciences Adds Two Accomplished Pathologists to Leadership Team
CND Life Sciences, Inc. (www.cndlifesciences.com), an innovative medical diagnostics company pioneering the detection, visualization, and […]
Geneos Therapeutics Secures $17 Million in Series A2 Financing to Advance Personalized Cancer Immunotherapy Platform
Geneos Therapeutics, a clinical stage biotherapeutics company focused on the development of tumor neoantigen targeted […]
Novartis Pluvicto™ Approved by FDA as First Targeted Radioligand Therapy for Treatment of Progressive, PSMA-positive Metastatic Castration-resistant Prostate Cancer
Novartis announced today that the US Food and Drug Administration (FDA) approved Pluvicto™ (lutetium Lu […]
Elysium Health™ Announces Research Partnership with the University of Oxford for the Purpose of Developing Epigenetic Measures of Brain Aging and Health
Elysium Health, Inc.™, a leading life sciences company focused on aging research, has entered into […]
Closed Loop Medicine Announces Completion of Precision Medicine Clinical Trial for Patients with High Blood Pressure
Closed Loop Medicine Ltd, a leader in the development of single prescription drug plus digital […]
Tollys Releases New Preclinical Data Demonstrating Lifelong Potent Anti-tumor Immunity of TL-532
Tollys, a biopharmaceutical company developing TL-532, the first anti-cancer immunotherapy based on a new generation […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more